Jeyarooban Jeyaneethi
London, ENG UB83PH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer.
Journal: Journal of clinical medicine
Published: August 04, 2022
Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In Vitro.
Journal: Journal of personalized medicine
Published: November 13, 2021
Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer.
Journal: Journal of clinical medicine
Published: March 29, 2021
H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer and Demonstrates Utility as a Prognostic Biomarker in Terms of Overall Survival.
Journal: Journal of clinical medicine
Published: July 12, 2020
Identification of Cancer-Associated Circulating Cells in Anal Cancer Patients.
Journal: Cancers
Published: July 11, 2020
Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer.
Journal: Frontiers in oncology
Published: March 22, 2019
Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry.
Journal: International journal of molecular medicine
Published: March 26, 2018
Involvement of the glutamine RF‑amide peptide and its cognate receptor GPR103 in prostate cancer.
Journal: Oncology reports
Published: January 24, 2018
Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers.
Journal: Carcinogenesis
Published: April 20, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026